Insider · CIK 0001343502

Richardson Peter C

Reports to the SEC for 3 companies · VALENCIA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001343502

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-31	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Chief Scientific Officer	AAward	+20.5K sh	—	—	27,357
2025-01-01	Keenova Therapeutics plcM Exercise/Conversion	EVP & Chief Scientific Officer	MExercise/Conversion	+3,419 sh	—	—	3,419
2025-01-01	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	EVP & Chief Scientific Officer	MExercise/Conversion	−3,419 sh	—	—	6,839
2024-02-02	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Chief Scientific Officer	AAward	−10.3K sh	—	—	10,258
2023-11-14	Keenova Therapeutics plcD Disposition to Issuer	EVP & Chief Scientific Officer	DDisposition to Issuer	−75.1K sh	—	—	0
2023-06-30	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	EVP & Chief Scientific Officer	DDisposition to Issuer	−128K sh	—	—	0
2023-04-03	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Chief Scientific Officer	AAward	+128K sh	—	—	127,861
2023-02-02	Keenova Therapeutics plcA Award	EVP & Chief Scientific Officer	AAward	+75.1K sh	—	—	75,091
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−36.2K sh	$5.60	−$203K	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−14.4K sh	$5.60	−$80.7K	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−59.2K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−69K sh	—	—	0
2021-06-10	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+36.2K sh	$4.42	+$160K	36,199
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+69K sh	—	—	69,037
2021-04-26	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+59.2K sh	—	—	59,179
2012-03-03	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−3,143 sh	$2.28	−$7,166.04	133,611
2011-08-19	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−1,091 sh	$2.41	−$2,629.31	137,972
2011-08-19	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−1,218 sh	$2.41	−$2,935.38	136,754
2011-08-15	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−1,091 sh	$2.79	−$3,043.89	139,063
2011-03-03	MNKDMANNKIND CORPA Award	Chief Scientific Officer	AAward	+15.5K sh	—	—	140,154
2011-03-03	MNKDMANNKIND CORP · Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+61.9K sh	$3.80	+$235K	61,900
2010-08-19	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−1,091 sh	$5.97	−$6,513.27	111,254
2010-08-19	MNKDMANNKIND CORPA Award	Chief Scientific Officer	AAward	+13.4K sh	—	—	124,654
2010-08-19	MNKDMANNKIND CORP · Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+65K sh	$5.93	+$385K	65,000
2010-08-16	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−319 sh	$6.53	−$2,083.07	112,345
2010-08-15	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−1,091 sh	$6.53	−$7,124.23	112,664
2010-08-01	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−4,135 sh	$6.91	−$28.6K	113,755
2010-02-01	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−4,607 sh	$10.12	−$46.6K	117,890
2010-01-14	MNKDMANNKIND CORPS Sale	Chief Scientific Officer	SSale	−22.7K sh	$10.00	−$227K	122,497
2009-08-26	MNKDMANNKIND CORPS Sale	Chief Scientific Officer	SSale	−1,334 sh	$7.79	−$10.4K	145,214
2009-08-19	MNKDMANNKIND CORPA Award	Chief Scientific Officer	AAward	+12K sh	—	—	146,548
2009-08-19	MNKDMANNKIND CORP · Employee Stock Option right to buy)A Award	Chief Scientific Officer	AAward	+43K sh	$7.48	+$322K	43,000
2009-08-01	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−8,270 sh	$8.03	−$66.4K	116,548
2009-06-30	MNKDMANNKIND CORPF Tax Payment	Chief Scientific Officer	FTax Payment	−19.2K sh	$8.44	−$162K	124,818
2009-05-18	MNKDMANNKIND CORPA Award	Chief Scientific Officer	AAward	+18K sh	—	—	161,993
2007-08-15	MNKDMANNKIND CORPA Award	Chief Scientific Officer	AAward	+12K sh	—	—	42,168
2007-08-15	MNKDMANNKIND CORP · Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+20K sh	$9.22	+$184K	20,000

Recent filings

Accepted (ET)
Aug 44
Richardson Peter C0001104659-25-073786
SEC(opens sec.gov)
Jan 24
Richardson Peter C0001104659-25-000369
SEC(opens sec.gov)
Feb 64
Richardson Peter C0001104659-24-011112
SEC(opens sec.gov)
Nov 164
Richardson Peter C0001104659-23-119117
SEC(opens sec.gov)
Jul 54
Richardson Peter C0001104659-23-078292
SEC(opens sec.gov)
Apr 54
Richardson Peter C0001104659-23-042293
SEC(opens sec.gov)
Feb 34
Richardson Peter C0001104659-23-010375
SEC(opens sec.gov)
May 264
Richardson Peter C0000899243-22-019794
SEC(opens sec.gov)
Jun 144
Richardson Peter C0001209191-21-040338
SEC(opens sec.gov)
Apr 284
Richardson Peter C0001209191-21-028856
SEC(opens sec.gov)
Mar 64
Richardson Peter C0001209191-12-016138
SEC(opens sec.gov)
Aug 194
Richardson Peter C0001209191-11-045094
SEC(opens sec.gov)
Mar 74
Richardson Peter C0001209191-11-016079
SEC(opens sec.gov)

Companies

Address

28903 NORTH AVENUE PAINE

VALENCIA, CA, 91355